Expression of the multidrug resistance P glycoprotein (Pgp) and multidrug resistance associated protein (MRP1) in Down syndrome brains

  • E. Engidawork
  • J. C. Roberts
  • R. Hardmeier
  • R. J. Scheper
  • G. Lubec


Transport by ATP-dependent efflux pumps such as P glycoprotein (Pgp) and multidrug resistance associated protein (MRP), encoded by multidrug resistant (MDR) associated genes, is an increasingly recognized mechanism by which cells maintain substrate homeostasis and evade drug therapy. Pgp and MRP are members of the so-called ATP binding cassette (ABC) transporters superfamily, which are associated with many biological processes in both prokaryotes and eukaryotes, as well as clinical problems. The observation of upregulated sequences that are homologous to the Mycobacterium smegmatis phage resistance (mpr) gene and putative ABC transporters subunits in fetal Down syndrome (DS) using the gene hunting technique, subtractive hybridization formed the Rationale for this study. The expression of Pgp and MRP1 is therefore investigated in different brain regions of controls and adult DS patients with western blot technique. No apparent changes were observed between controls and DS in levels of Pgp in all brain regions examined. By contrast, MRP1 detection using the rat monoclonal antibody (MRPrl) produced a significant elevation in DS temporal cortex (P < 0.01) and parietal cortex (P < 0.05). Although MRP1 detected with the mouse monoclonal antibody (MRPm6) tended to increase in most of the regions of DS brain, it failed to reach significance level. Age or postmortem interval did not correlate with protein levels in both controls as well as DS. Taken together, the current data provide evidence for the presence of MDR related pumps in different regions of the human brain. In addition, overexpression of MRP1 in DS brain may have some relevance to the disorder either by deranging substrate homeostasis or limiting drug access.


Down Syndrome Multidrug Resistance Multi Drug Resistance Associate Protein Multidrug Resistance Protein Multidrug Resistance Related Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of active oxygen species in Down syndrome neurons in vitro. Nature 378: 776–779PubMedCrossRefGoogle Scholar
  2. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EV, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug resistance human lung cancer cell line. Science 258: 1650–1654PubMedCrossRefGoogle Scholar
  3. Decleves X, Regina A, Laplanche JL, Roux F, Boval B, Launay JM, Scherrmann JM (2000) Functional expression of P-glycoprotein and multidrug resistance associated protein (MRP1) in primary cultures of astrocytes. J Neurosci Res 60: 594–601PubMedCrossRefGoogle Scholar
  4. Epstein CJ (2001) Down syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 1223–1256Google Scholar
  5. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ, Zaman GJR (1994) Immunohistochemical detection of the multidrug resistance associated protein MRP in human multidrug resistant tumor cell by monoclonal antibodies. Cancer Res 54: 4557–4563PubMedGoogle Scholar
  6. Fromm MF (2000) P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38: 69–74PubMedGoogle Scholar
  7. Ghersi-Egea JF, Strazielle N (2001) Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus. Microsc Res Tech 52: 83–88PubMedCrossRefGoogle Scholar
  8. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug resistance transporter. Annu Rev Biochem 62: 385–427PubMedCrossRefGoogle Scholar
  9. Grandjean F, Bremaud L, Verdier M, Robert J, Ratinaud M-H (2001) Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicinresistant human K562 cell lines. Anti-Cancer Drugs 12: 247–258PubMedCrossRefGoogle Scholar
  10. Greber-Platzer S, Lubec G, Langen H, Fountoulakis M (1999) Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer’s disease. Electrophoresis 20: 928–934CrossRefGoogle Scholar
  11. Higgins CF (1992) ABC transporters: From microorganisms to man. Annu Rev Cell Biol 8: 67–113PubMedCrossRefGoogle Scholar
  12. Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF, Miller DW (1998) Expression of Multidrug-Resistance associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun 243: 816–820PubMedCrossRefGoogle Scholar
  13. Iannello RC, Crack PJ, de Haan JW, Kola I (1999) Oxidative stress and neural dysfunction in Down syndrome. J Neural Transm 57: 257–267Google Scholar
  14. Ischikawa I (1992) The ATP dependent glutathione-S export pump. Trends Biochem Sci 17:463–468CrossRefGoogle Scholar
  15. Jirsch J, Deeley RG, Cole SPC, Stewart AJ, Fedida D (1993) Inwardly rectifying potassium channels and volume regulated anion channels in multidrug resistant small cell lung cancer. Cancer Res 53: 4156–4160PubMedGoogle Scholar
  16. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJT, Juijin JA, Baas F, Borst P (1997) Analysis of expression CMOAT (MRP2), MRP3, MRP4, and MRP5, homoogues of MRP1 in human cancer cell lines. Cancer Res 57: 3537–3547PubMedGoogle Scholar
  17. Kool M, van der Linden M, de Haas F, Borst P (1999) Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59: 175–182PubMedGoogle Scholar
  18. Krishnamachary N, Center MS (1993) The MRP gene associated with a non-P glycoprotein multidrug resistance encodes a 190 kDa membrane bound glycoprotein. Cancer Res 53: 3658–3661PubMedGoogle Scholar
  19. Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40: S3–8PubMedCrossRefGoogle Scholar
  20. Loe DW, Deeley RG, Cole SPC (1996) Biology of the multidrug resistance associated protein, MRP. Eur J Cancer 32A: 945–957PubMedCrossRefGoogle Scholar
  21. Loe DW, Deeley RG, Cole SPC (1998) Characterization of vincristine transport by the Mr 190000 multidrug resistant protein (MRP): evidence for co-transport with reduced glutathione. Cancer Res 58: 5130–5136PubMedGoogle Scholar
  22. Mohri M, Nitta H, Yamashita J (2001) Expression of multidrug resistance associated protein in human gliomas. J Neurooncol 49: 105–115CrossRefGoogle Scholar
  23. Payen L, Courtois A, Loewert M, Guillouzo A, Fardel O (2001) Reactive oxygen species related induction of multidrug resistance associated protein2 expression in primary hepatocytes exposed to sulforaphane. Biochem Biophys Res Commun 282: 257–263PubMedCrossRefGoogle Scholar
  24. Rao V, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica- Worms D (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance associated protein contribute to the blood cerebrospinal fluid drug permeability barrier. Proc Natl Acad Sci USA 96: 3900–3905PubMedCrossRefGoogle Scholar
  25. Rappa G, Lorico A, Flavell RA, Sartorelli AC (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57: 5232–5237PubMedGoogle Scholar
  26. Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, Roux F (1998) Mrpl multidrug resistance associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71: 705–715PubMedCrossRefGoogle Scholar
  27. Renes J, de Vries EEG, Hooiveld GJEJ, Krikken I, Jansen PLM, Müller M (2000) The multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem J 350: 555–561PubMedCrossRefGoogle Scholar
  28. Scheper RJ, Bulte JW, Brakkee JGP, Quak JJ, van Der Schoot E, Balm AJM, Meijer CJLM, Broxterman HJ, Kuiper CM, Lankelma J, Pinedo HM (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycosylation associated with multidrug resistance. Int J Cancer 42: 389–394PubMedCrossRefGoogle Scholar
  29. Seetharaman S, Barrand MA, Maskell L, Scheper RJ (1998) Multidrug resistance related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. Neurochem 70: 1151–1119CrossRefGoogle Scholar
  30. Wang F, Dong Z, Luo J (1998) The clinical significance of multidrug resistance associated (MRP) gene exression in acute leukemia. Zhonghua Xve Ye Xue Za Zhi 19: 63–66Google Scholar
  31. Yamane Y, Furuichi, Song R, Van NT, Mulcahy RT, Ishikawa T, Kuo MT (1998) Expression of multidrug resistance protein/GS-X pump and y-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem 273: 31075–31085PubMedCrossRefGoogle Scholar
  32. Zaman GJR, Versantvoort CHM, Smith JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multi drug resistant lung cancer cell lines. Cancer Res 53: 1747–1750PubMedGoogle Scholar
  33. Zhang Y, Han H, Elmquist WF, Miller DW (2000) Expression of various multidrug resistance associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 876: 148–153PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2001

Authors and Affiliations

  • E. Engidawork
    • 1
  • J. C. Roberts
    • 2
  • R. Hardmeier
    • 1
  • R. J. Scheper
    • 3
  • G. Lubec
    • 1
  1. 1.Department of PediatricsUniversity of ViennaViennaAustria
  2. 2.Department of Medical ChemistryUniversity of UtahSalt Lake CityUSA
  3. 3.Department of PathologyFree University HospitalAmsterdamThe Netherlands

Personalised recommendations